Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
about
Endothelial-Mesenchymal Transition in Regenerative MedicineExpression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour sizeExpression of hypoxia inducible factor-1alpha during liver regeneration induced by partial hepatectomy in ratsThe translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis.Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase.Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-1 and gene expression.ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancerRoles of vascular endothelial growth factor in amyotrophic lateral sclerosis.Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approachMolecular markers of metastasis in squamous carcinomas.Physiological and pathological responses to hypoxia.Current limitations of murine models in oncology for ascorbate research.Review of treatment assessment using DCE-MRI in breast cancer radiation therapy.Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway.Ventilatory chemosensory drive is blunted in the mdx mouse model of Duchenne Muscular Dystrophy (DMD).Inhibition of Raf-MEK-ERK and hypoxia pathways by Phyllanthus prevents metastasis in human lung (A549) cancer cell lineF-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapyTumor-specific gene expression using the survivin promoter is further increased by hypoxiaHEXIM1 down-regulates hypoxia-inducible factor-1α protein stability.Measuring tumour vascular response to antivascular and antiangiogenic drugs.A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.Cyclooxygenase-2 expression and angiogenesis in colorectal cancer.Metastasis: recent discoveries and novel treatment strategies.Effects of PI3K and p42/p44 MAPK on overexpression of vascular endothelial growth factor in hepatocellular carcinoma.The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgeryThe effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model.Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma.Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations.Relationship of hypoxia to metastatic ability in rodent tumoursCXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growthWortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cellsQuantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomasBiomolecular markers in cancer of the tongue.Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.Plasticity of disseminating cancer cells in patients with epithelial malignancies.Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche.3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways.
P2860
Q26752901-49D1AF1F-5506-405E-B4B5-C391850D04FCQ28565213-5CBEC151-754D-4D47-8370-B8058486ADCBQ28581724-4EE622B6-379A-4AEA-B1A1-8045A175C9E9Q30591171-AFC95438-F204-42C8-9A5D-5A9249F0FA1FQ33220470-A90EC3A1-0A66-42F3-9910-CBCCE14AE4BAQ33265941-6314431D-57D4-411C-BA30-CF3ECA63C204Q33354649-403A64B5-E468-467A-B675-62FB9FD2C20DQ33402694-8854FE68-046C-45CE-A9E5-3D541CADDFA5Q33616384-7A3C3B2A-F6A1-4E4F-8090-5F2FE370F376Q33947892-55CBED33-49C1-46E5-AB8C-A055BC74673FQ34151551-88CB7137-9DAD-4E24-BCD1-699119E2DE72Q34299992-3B4D7C76-20AB-44B8-B596-CEEC51B17D07Q34322819-BDAD3184-598F-4D9D-B524-FD28B46C7C25Q34336161-D4234C1C-5E30-4499-AC23-9218CF2697C8Q34367593-9709FA24-C773-4CDF-980E-2ED5218CFF7DQ34541713-4731559E-335C-48E8-A27E-5502FADAAA43Q34903075-D7668798-89AE-46B0-BEA7-720BD4363338Q35020574-B933E04A-9B1C-4D5D-8893-502207E6C798Q35116993-41EC40E6-733F-4379-B6B3-7C615EB4FAFCQ35184871-1F180284-325B-49E6-9BEF-61FD24EC5267Q35602354-63756656-89D8-4305-B42C-54B4979F085AQ35904992-9FF50D73-00FB-4577-8B32-AD32A77F3165Q36056814-BC136938-4F00-4847-98C6-8711108C44C3Q36179801-0BA0EA86-CF5B-4941-BBB3-AAD72780A449Q36407511-E2E9320E-FB97-49FB-A90A-E218B40F80F5Q36502607-AA9A8517-7149-456A-81CB-C39B11FDD1C1Q36611754-F48C6C72-D637-4B15-8F08-67D80DF2216FQ36613531-2414536E-43CD-470A-ACE7-CAC041BAB071Q36615053-075AAC22-6EF8-4DD6-A781-C4E49FA794CEQ36622927-AFFAF119-5A7E-4EF0-A981-88361987D857Q36622970-8FAA359B-2831-487C-957B-ACE34AE49C7FQ36693212-D4D73AF3-EA31-4EAE-AE89-5F89C02C33A4Q36919444-AB82B2A1-2908-4838-B9F3-BFD5FC9A0BAFQ37140172-41A6F7C9-6235-4AF9-81C5-541C9FDA7B7BQ37310520-924E1D5D-4D7D-41BC-908E-D738E1D200A8Q37723067-1AE3C880-9F10-4A23-8372-408B5D8A3038Q38021683-77F483A5-E436-4501-9335-AED2BDD718E0Q38668174-40B5A7CC-E8FB-45E4-86C9-409AAB6B05CAQ39186868-E1224DEB-ABE8-47C6-ACA7-5CB35305CE85Q39415018-3ED26C83-793A-4DDE-A476-60E2B29D4741
P2860
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@ast
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@en
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@nl
type
label
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@ast
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@en
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@nl
prefLabel
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@ast
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@en
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@nl
P1476
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.
@en
P2093
P304
P356
10.1016/S0959-8049(00)00159-3
P433
13 Spec No
P577
2000-08-01T00:00:00Z